Global RNAi Technology Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global RNAi Technology Market was valued at $3.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 14.8% CAGR, to an estimated market size of $7.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global RNAi technology market comprises the development and application of gene-silencing mechanisms, specifically utilizing small interfering RNA (siRNA), microRNA (miRNA), and short hairpin RNA (shRNA) to neutralize targeted mRNA molecules. The scope includes therapeutics for genetic and chronic diseases, drug discovery tools, and applications in agricultural biotechnology for pest control.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the RNAi Technology Market in the period 2025-30:
- Advancements in delivery mechanisms, particularly GalNAc conjugates and lipid nanoparticles, are overcoming historical barriers to stability and bioavailability.
- The market is expanding from rare genetic disorders into large-market indications such as cardiovascular disease, oncology, and chronic infectious diseases.
- Integration of Artificial Intelligence and machine learning is accelerating target discovery and reducing validation times for novel RNAi sequences.
- Increased strategic collaborations between specialized biotech firms and global pharmaceutical leaders are fueling the clinical pipeline and commercialization.
- Supportive regulatory pathways, including orphan drug and breakthrough designations, are facilitating faster market entry for gene-silencing therapies.
- A growing shift toward personalized medicine is positioning RNAi as a primary tool for addressing specific genetic mutations and individual patient profiles.
- Emerging applications in agricultural biotechnology are utilizing RNAi for sustainable, non-toxic pest control and crop protection.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- siRNA
- miRNA
- shRNA and Others